Circulating markers of cellular immune activation in pre-diagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)
International Journal of Cancer Jul 10, 2019
Huang JY, et al. - Given a possible significant role of cell-mediated immune suppression in lung carcinogenesis, researchers examined 5,364 smoking-matched case-control pairs from 20 prospective cohorts included in the international Lung Cancer Cohort Consortium, for the associations for circulating levels of tryptophan, kynurenine, kynurenine:tryptophan ratio (KTR), quinolinic acid (QA), and neopterin as markers of immune regulation and inflammation with lung cancer risk. Serum/plasma samples collected on average 6 years before lung cancer diagnosis were examined for all biomarkers using mass spectrometry-based methods. Outcomes revealed an association between components of the tryptophan-kynurenine pathway with immunomodulatory effects and the risk of lung cancer overall. This association was particularly evident among current smokers.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries